Skip to main content
Clinical Trials/EUCTR2017-004497-33-DK
EUCTR2017-004497-33-DK
Active, not recruiting
Phase 1

Measuring effects on pain and quality of life after Dysport® injection in children with cerebral palsy

Copenhagen University Hospital at Hvidovre0 sites36 target enrollmentDecember 22, 2017

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Muscle pain in the extremities due to spasticity in children with cerebral palsy
Sponsor
Copenhagen University Hospital at Hvidovre
Enrollment
36
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 22, 2017
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Copenhagen University Hospital at Hvidovre

Eligibility Criteria

Inclusion Criteria

  • \- Diagnosed with spastic cerebral palsy
  • \- GFMCS 1\-5\.
  • \- Age 2\-18
  • \- Having a pain response by the revised and individualized Face Legs Activity Cry and Consolability (rFLACC) for muscles with spasticity (MAS score \= 1 and a spasticity grade of 1\-4 on the Tardieu scale) during the passive range of motion by the treating physician.
  • \- Requiring BonTA injection for their spasticity
  • \- having had a washout period of at least 6 month from last injection of botulinum toxin
  • \- Dynamic Myocontracture /spasticity in the painful limb (MAS score \= 1 and a spasticity grade of 1\-4 on the Tardieu scale)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 36
  • F.1\.2 Adults (18\-64 years) no

Exclusion Criteria

  • \- Fixed myocontracture (Reduced and static passive range of motion)
  • \- Severe athetoid/dystonic movements in the targeted leg(s)
  • Relative exclusion criteria
  • Prior and recent surgery that might influence the pain evaluation is a contraindication and will be evaluated on an individual basis for the specific test subject by the principle investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials